CiVi Biopharma is a privately held company that was founded in 2017. 

To date, the Company has raised approximately ~$120 million and is supported by leading venture and corporate investors, including Boxer Capital, Tang Capital, Roche Ventures, RA Capital and a leading NYC-based biotechnology investment fund.